Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: bentway who wrote (381370)	4/30/2008 12:36:19 AM
From: Tenchusatsu	Read Replies (1) \| Respond to of 1574104

Chris, > The Pharma companies tweak old drugs, call them new or change the formulation to sell them under patent. Savings can be had even on generics. I don't see how these two statements are related. The U.S. Patent Office (or whichever federal agency deals with this) has to stop giving new patents for the same reformulations on different drugs. That is a given. But what does that have to do with generics? > WalMart sells 300 generics for $4 for 30. Does your wife work there yet? THEY negotiate prices with ALL their suppliers. Considering how Wal-mart has killed small businesses, I think the analogy between the government and Wal-mart is very apt. Tenchusatsu